Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Translational Therapeutics (United States) · University of Pennsylvania · +3 more institutions
Abstract
Immune profiling of COVID-19 patients Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathew et al. present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalam et al. report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These studies provide a compendium of immune cell information and roadmaps for potential…
Citation impact
- FWCI
- 36.40
- Percentile
- 100%
- References
- 64
Authors
55- DMDivij MathewCorresponding
Translational Therapeutics (United States), University of Pennsylvania
- JRJosephine R. GilesCorresponding
Parker Institute for Cancer Immunotherapy, Translational Therapeutics (United States), University of Pennsylvania
- AEAmy E. BaxterCorresponding
Translational Therapeutics (United States), University of Pennsylvania
- DADerek A. OldridgeCorresponding
University of Pennsylvania
- ARAllison R. GreenplateCorresponding
Translational Therapeutics (United States), University of Pennsylvania
Topics & keywords
- Coronavirus disease 2019 (COVID-19)
- Profiling (computer programming)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Immune system
- 2019-20 coronavirus outbreak
- Virology
- Biology
- Medicine
- Good health and well-being